The pharmaceutical industry has finally reached a revolutionary breakthrough: Bellacara. The contraception pill of the fourth generation becomes a lifestyle-product but when a study discovers dangerous adverse reactions, the pharma company that Karsten Gellhaus works for is the least bit interested.